Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anxiety management in third molar surgery comparing zolpidem, Passiflora incarnata, midazolam, and placebo
RBR-4knsh9zPhase 2Terminated
- Sponsor
- Universidade Estadual Paulista
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial of zolpidem, passiflora incarnata, midazolam and Placebo-COD Research Private Ltd in anxiety disorder (4 arms), sponsored by Universidade Estadual Paulista. Started Oct 2021; status: terminated.
02
Drugs
zolpidempassiflora incarnatamidazolamPlacebo-COD Research Private Ltd
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on RBR-4knsh9z.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4knsh9z.